Insider Transactions

Bank of New York Mellon Corp (BK) Insider Transactions

Over the last 12 months, 20 Bank of New York Mellon Corp (BK) insiders filed 77 SEC Form 4 transactions — $0 in open-market purchases ( 0 distinct buyers) and $8.5M in open-market sales. 0% of all transactions were executed under a pre-scheduled Rule 10b5-1 trading plan.

Recent Form 4 Filings Most recent 50 of 77 (1-year window)

Each row is a single Form 4 filing event for BK, sourced directly from SEC EDGAR. The Type column classifies the SEC transaction code into Buy / Sell / Grant / Exercise / Other; the 10b5-1 badge marks trades executed under a pre-scheduled SEC Rule 10b5-1 plan.

Date Insider Title Type SEC Code Value Shares Price
2026-04-17 COOK LINDA Z Grant A $0 1,592
2026-04-17 Echevarria Joseph Grant A $0 1,592
2026-04-17 Gilliland Marguerite Amy Grant A $0 1,592
2026-04-17 Gowrappan Kumara Guru Grant A $0 1,592
2026-04-17 Goldstein Jeffrey A Grant A $0 1,592
2026-04-17 Lowrey Charles F Grant A $0 1,592
2026-04-17 O'CONNOR SANDRA Grant A $0 1,592
2026-04-17 Robinson Elizabeth Grant A $0 1,592
2026-04-17 Russak-Aminoach Rakefet Grant A $0 1,592
2026-04-17 ZOLLAR ALFRED W Grant A $0 1,592
2026-04-17 Perez Alejandro Sr. Executive Vice President Other G $0 1,000 $0.00
2026-04-17 Perez Alejandro Sr. Executive Vice President Sell S $1.7M 12,504 $137.01
2026-04-17 Kurimsky Kurtis R. Corporate Controller Sell S $719.5K 5,290 $136.02
2026-04-17 McCarthy J Kevin SEVP & General Counsel Sell S $4.1M 30,000 $136.50
2026-04-17 Hobbs Shannon Marie Senior Executive VP Sell S $40.7K 297 $137.05
2026-04-01 Robinson Elizabeth Grant A $10.6K 88 $120.97
2026-04-01 O'CONNOR SANDRA Grant A $27.5K 227 $120.97
2026-04-01 IZZO RALPH Grant A $27.5K 227 $120.97
2026-04-01 Goldstein Jeffrey A Grant A $41.3K 341 $120.97
2026-04-01 Echevarria Joseph Grant A $90.0K 744 $120.97
2026-02-28 Datta Rajashree Senior Executive VP Grant $226.3K 1,900 $119.10
2026-02-28 Datta Rajashree Senior Executive VP Grant $779.0K 6,541 $119.10
2026-02-28 McDonogh Dermot Chief Financial Officer Grant $608.5K 5,109 $119.10
2026-02-28 McDonogh Dermot Chief Financial Officer Grant $3.3M 27,684 $119.10
2026-02-28 Minaya Jose Senior Executive VP Grant $5.4M 45,584 $119.10
2026-02-23 Vince Robin A. Chairman & CEO Grant $0 183,759 $0.00
2026-02-23 Vince Robin A. Chairman & CEO Grant $11.7M 101,619 $115.54
2026-02-23 McDonogh Dermot Chief Financial Officer Grant $0 56,818 $0.00
2026-02-23 McDonogh Dermot Chief Financial Officer Grant $3.6M 31,421 $115.54
2026-02-23 McCarthy J Kevin SEVP & General Counsel Grant $0 52,501 $0.00
2026-02-23 McCarthy J Kevin SEVP & General Counsel Grant $3.4M 29,034 $115.54
2026-02-15 Vince Robin A. Chairman & CEO Grant $1.5M 12,631 $117.74
2026-02-15 Vince Robin A. Chairman & CEO Grant $2.1M 18,019 $117.74
2026-02-15 Vince Robin A. Chairman & CEO Grant $1.4M 12,139 $117.74
2026-02-15 Koffey Jayee Sr. Exec. Vice President Grant $399.7K 3,395 $117.74
2026-02-15 Koffey Jayee Sr. Exec. Vice President Grant $361.3K 3,069 $117.74
2026-02-15 Koffey Jayee Sr. Exec. Vice President Grant $233.4K 1,982 $117.74
2026-02-15 Datta Rajashree Senior Executive VP Grant $542.3K 4,606 $117.74
2026-02-15 Minaya Jose Senior Executive VP Grant $786.6K 6,681 $117.74
2026-02-15 Hobbs Shannon Marie Senior Executive VP Grant $146.1K 1,241 $117.74
2026-02-15 McCarthy J Kevin SEVP & General Counsel Grant $637.3K 5,413 $117.74
2026-02-15 McCarthy J Kevin SEVP & General Counsel Grant $612.5K 5,202 $117.74
2026-02-15 McCarthy J Kevin SEVP & General Counsel Grant $415.6K 3,530 $117.74
2026-02-15 Kurimsky Kurtis R. Corporate Controller Grant $271.7K 2,308 $117.74
2026-02-15 Kurimsky Kurtis R. Corporate Controller Grant $251.3K 2,134 $117.74
2026-02-15 Kurimsky Kurtis R. Corporate Controller Grant $197.6K 1,678 $117.74
2026-02-15 McDonogh Dermot Chief Financial Officer Grant $689.7K 5,858 $117.74
2026-02-15 McDonogh Dermot Chief Financial Officer Grant $1.1M 9,228 $117.74
2026-02-15 McDonogh Dermot Chief Financial Officer Grant $797.8K 6,776 $117.74
2026-02-02 Datta Rajashree Senior Executive VP Grant $0 21,278 $0.00

Showing the most recent 50 of 77 transactions. For the full 1-year history with sorting, filtering, and cross-ticker industry context, open the full insider transactions drilldown.

Methodology & FAQ

How We Track BK Insider Transactions

Form 4 disclosures are sourced directly from SEC EDGAR and re-ingested on every pipeline cycle. A complete description of transaction-code handling, the open-market vs grant distinction, and the Rule 10b5-1 plan-reference heuristic is documented in the Methodology.

What is an SEC Form 4 filing for Bank of New York Mellon Corp?

Form 4 is a transaction-level disclosure that corporate insiders — officers, directors, and beneficial owners of more than 10% of a registered class of equity securities — must file with the SEC within two business days of any change in their beneficial ownership of Bank of New York Mellon Corp (BK) shares.

What is a Rule 10b5-1 trading plan?

Rule 10b5-1 is an SEC rule that lets insiders schedule trades in advance under a written plan, providing an affirmative defense against insider-trading allegations as long as the plan was adopted in good faith and not while in possession of material non-public information. Form 4 rows marked "10b5-1" on this page indicate the underlying trade was executed under such a plan; rows without the badge are discretionary or did not reference a plan in the Form 4 footnotes.

How is "insider buying" different from a stock grant or option exercise?

An insider buy (SEC transaction code P) is an open-market purchase of Bank of New York Mellon Corp (BK) stock executed at the prevailing market price using the insider's personal capital. Stock grants (code A) and option exercises (code M) are compensation events, not directional trades; they are tracked separately and excluded from the "conviction" signal because they are not discretionary purchases.

How recent is the data?

Form 4 transactions are typically reported within two business days of execution. Pactolio re-ingests the EDGAR feed on a nightly cycle and reflects new filings on the next ingest run, typically within 24 hours of EDGAR acceptance. The table on this page covers the most recent 1-year window.